RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Korean Drug Co Stock

Korean Drug Co Equity 2024

Korean Drug Co Equity

77.09 B KRW

Ticker

014570.KQ

ISIN

KR7014570006

In 2024, Korean Drug Co's equity was 77.09 B KRW, a -9% increase from the 84.71 B KRW equity in the previous year.

Korean Drug Co Aktienanalyse

What does Korean Drug Co do?

Korean Drug Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Korean Drug Co's Equity

Korean Drug Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Korean Drug Co's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Korean Drug Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Korean Drug Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Korean Drug Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Korean Drug Co stock

What is the equity of Korean Drug Co this year?

Korean Drug Co has equity of 77.09 B KRW this year.

What was the equity of Korean Drug Co compared to the previous year?

The equity of Korean Drug Co has increased/decreased by -9% decreased compared to the previous year.

What impact does a high equity have on investors of Korean Drug Co?

A high equity is advantageous for investors of Korean Drug Co as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Korean Drug Co?

A low equity can be a risk for investors of Korean Drug Co, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Korean Drug Co affect the company?

An increase in equity of Korean Drug Co can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Korean Drug Co affect the company?

A reduction in equity of Korean Drug Co can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Korean Drug Co?

Some factors that can affect the equity of Korean Drug Co include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Korean Drug Co so important for investors?

The equity of Korean Drug Co is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Korean Drug Co take to change the equity?

To change equity, Korean Drug Co can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Korean Drug Co pay?

Over the past 12 months, Korean Drug Co paid a dividend of 150 KRW . This corresponds to a dividend yield of about 3.21 %. For the coming 12 months, Korean Drug Co is expected to pay a dividend of 150 KRW.

What is the dividend yield of Korean Drug Co?

The current dividend yield of Korean Drug Co is 3.21 %.

When does Korean Drug Co pay dividends?

Korean Drug Co pays a quarterly dividend. This is distributed in the months of January, January, January, January.

How secure is the dividend of Korean Drug Co?

Korean Drug Co paid dividends every year for the past 20 years.

What is the dividend of Korean Drug Co?

For the upcoming 12 months, dividends amounting to 150 KRW are expected. This corresponds to a dividend yield of 3.21 %.

In which sector is Korean Drug Co located?

Korean Drug Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Korean Drug Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Korean Drug Co from 4/5/2024 amounting to 150 KRW, you needed to have the stock in your portfolio before the ex-date on 12/27/2023.

When did Korean Drug Co pay the last dividend?

The last dividend was paid out on 4/5/2024.

What was the dividend of Korean Drug Co in the year 2023?

In the year 2023, Korean Drug Co distributed 180 KRW as dividends.

In which currency does Korean Drug Co pay out the dividend?

The dividends of Korean Drug Co are distributed in KRW.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Korean Drug Co

Our stock analysis for Korean Drug Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Korean Drug Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.